Scientists in the US who do research on mRNA technology worry their funding may be cut under President Trump. mRNA technology is the basis for COVID- and other vaccines and could play a role in cancer ...
The CDC has rescheduled a key advisory committee meeting on vaccine experts to April following a delay in February, a week ...
Rep. Marjorie Taylor Greene calls for yanking FDA approval of COVID-19 vaccines, says that "COVID-19 vaccines are causing ...
For most of America, on March 11, 2020, COVID became real. On that day, The World Health Organization declared the novel coronavirus an official “pandemic.” Two days later, then President Donald Trump ...
The U.S. Department of Agriculture (USDA) on Thursday announced a $100M investment to combat the transmission of the bird flu ...
The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.
The recombinant zoster vaccine is effective in preventing herpes zoster in adults aged 50 years or older with rheumatoid ...
The pharmaceutical company said, “The allegations that came out in the media are entirely baseless, distorted, and part of a smear campaign" ...
The National Institutes of Health are the world’s largest funder of medical research, distributing $35 billion in in grants ...
A handful of states are targeting the technology at the same time the Trump administration is cutting research funding and ...
VOV.VN - Pfizer Vietnam Company Limited (Pfizer VN) and Vietnam Vaccine Joint Stock Company (VNVC) signed a Memorandum of ...
Given the uncertainty around its top-line growth, short-term investors should exercise caution when investing in MRNA stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results